Sort by
Weight Loss Support - Returning Patients
Weight Loss Support for patients who are currently on GLP -1 program
- Tirzepatide – Phase 3 Advanced - 3 Months Supply
- Maximum efficacy. Highest therapeutic dose for sustained long-term results. 3-month supply covers months 7–9; month 10 billed separately at $450.
- Semaglutide – Phase 3 Advanced - 3 Months Supply
- Maximum therapeutic dose. Continued and sustained weight loss. 3-month supply covers months 7–9; month 10 billed separately.
- Tirzepatide – Phase 3 Advanced - 1 Month Supply
- Full steady-state therapeutic dose. Monthly billing makes it easy to stay on program.
- Semaglutide – Phase 3 Advanced - 1 Month Supply
- Maximum therapeutic dose. Price increases slightly to reflect higher medication volume at the advanced dose.
- Tirzepatide – Phase 2 Intermediate - 3 Months Supply
- Your full therapeutic dose. GLP-1 and GIP receptor activation at scale. Most patients experience significant weight loss during this phase.
- Semaglutide – Phase 2 Intermediate - 3 Months Supply
- Standard therapeutic dose. Active weight loss phase. Most patients see consistent, measurable results throughout this phase.
- Tirzepatide – Phase 2 Intermediate - 1 Month Supply
- Intermediate therapeutic dose. Monthly billing continues seamlessly.
- Semaglutide – Phase 2 Intermediate - 1 Month Supply
- Intermediate therapeutic dose. Monthly billing continues seamlessly.